Moolec Science SA (NASDAQ:MLEC) Short Interest Update

Moolec Science SA (NASDAQ:MLECGet Free Report) was the target of a large decline in short interest in February. As of February 29th, there was short interest totalling 20,800 shares, a decline of 17.5% from the February 14th total of 25,200 shares. Currently, 0.7% of the company’s stock are sold short. Based on an average daily trading volume, of 315,800 shares, the short-interest ratio is presently 0.1 days.

Moolec Science Trading Down 1.8 %

MLEC stock traded down $0.03 during mid-day trading on Friday, reaching $1.63. 8,659 shares of the company traded hands, compared to its average volume of 393,813. The company has a debt-to-equity ratio of 0.03, a current ratio of 0.26 and a quick ratio of 0.22. Moolec Science has a fifty-two week low of $1.58 and a fifty-two week high of $5.94. The firm’s 50 day moving average price is $1.91 and its 200 day moving average price is $2.44.

Moolec Science (NASDAQ:MLECGet Free Report) last released its quarterly earnings results on Thursday, December 14th. The company reported ($0.04) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.01. The company had revenue of $1.74 million for the quarter, compared to analyst estimates of $0.63 million. On average, analysts predict that Moolec Science will post -0.19 EPS for the current fiscal year.

Hedge Funds Weigh In On Moolec Science

A hedge fund recently bought a new stake in Moolec Science stock. Geode Capital Management LLC bought a new position in Moolec Science SA (NASDAQ:MLECFree Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 12,378 shares of the company’s stock, valued at approximately $51,000. Geode Capital Management LLC owned about 0.20% of Moolec Science at the end of the most recent reporting period. 0.41% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, Maxim Group initiated coverage on Moolec Science in a research report on Tuesday, January 30th. They issued a “buy” rating and a $6.00 target price for the company.

Check Out Our Latest Stock Analysis on Moolec Science

Moolec Science Company Profile

(Get Free Report)

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product.

See Also

Receive News & Ratings for Moolec Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moolec Science and related companies with's FREE daily email newsletter.